Humacyte, Inc.HUMAEarnings & Financial Report
Nasdaq
NextMar 13, 2026
HUMA Q3 2025 Key Financial Metrics
Revenue
$753.0K
Gross Profit
$493.0K
Operating Profit
$-24.4M
Net Profit
$-17.5M
Gross Margin
65.5%
Operating Margin
-3239.0%
Net Margin
-2325.4%
YoY Growth
N/A
EPS
$-0.11
Financial Flow
Humacyte, Inc. Q3 2025 Financial Summary
Humacyte, Inc. reported revenue of $753.0K for Q3 2025, with a net profit of $-17.5M (-2325.4% margin). Cost of goods sold was $260.0K, operating expenses totaled $24.9M.
Key Financial Metrics
| Total Revenue | $753.0K |
|---|---|
| Net Profit | $-17.5M |
| Gross Margin | 65.5% |
| Operating Margin | -3239.0% |
| Report Period | Q3 2025 |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $517000 | $301000 | $753000 |
| YoY Growth | N/A | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|
| Assets | $161.5M | $138.3M | $114.8M | $162.6M | $138.8M | $91.5M |
| Liabilities | $135.3M | $166.6M | $178.5M | $126.5M | $134.7M | $96.3M |
| Equity | $26.2M | $-28.3M | $-63.7M | $36.0M | $4.1M | $-4.8M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|
| Operating CF | $-27.3M | $-21.3M | $-22.9M | $-28.6M | $-26.4M | $-23.9M |